Home > Insider Trading > Filing (0001437749-20-010441)

Filing Details

Accession Number:: 0001437749-20-010441
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-05-12 16:49:24
Reporting Period:: 2020-05-08

Accepted Time:: 2020-05-12 16:49:24
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1586049	Oxford Immunotec Global Plc	OXFD	In Vitro & In Vivo Diagnostic Substances (2835)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1592286	Peter Wrighton-Smith	C/O Oxford Immunotec Global Plc 94C Innovation Drive Abingdon, Oxfordshire X0 OX14 4RZ	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Ordinary Shares	Acquisiton	2020-05-08	2,075	$10.75	358,700	No	4	P	Direct
Ordinary Shares	Acquisiton	2020-05-11	26,000	$11.45	384,700	No	4	P	Direct
Ordinary Shares	Acquisiton	2020-05-12	15,525	$11.56	400,225	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

The price reported for the purchase on May 8, 2020 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.6700 to $10.8300 per share, inclusive. The reporting person undertakes to provide Oxford Immunotec Global PLC, or any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4.
The price reported for the purchase on May 11, 2020 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.1550 to $11.7500 per share, inclusive. The reporting person undertakes to provide Oxford Immunotec Global PLC, or any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (2) to this Form 4.
The price reported for the purchase on May 12, 2020 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.5100 to $11.6400 per share, inclusive. The reporting person undertakes to provide Oxford Immunotec Global PLC, or any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (3) to this Form 4.